RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Astec Lifesciences Stock

Astec Lifesciences Liabilities 2025

Astec Lifesciences Liabilities

6.06 B INR

Ticker

ASTEC.NS

ISIN

INE563J01010

In 2025, Astec Lifesciences's total liabilities amounted to 6.06 B INR, a 8.14% difference from the 5.6 B INR total liabilities in the previous year.

Astec Lifesciences Aktienanalyse

What does Astec Lifesciences do?

Astec Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Astec Lifesciences's Liabilities

Astec Lifesciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Astec Lifesciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Astec Lifesciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Astec Lifesciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Astec Lifesciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Astec Lifesciences stock

What is the level of liabilities of Astec Lifesciences this year?

Astec Lifesciences has a debt balance of 6.06 B INR this year.

What were the liabilities of Astec Lifesciences compared to the previous year?

The liabilities of Astec Lifesciences have increased by 8.14% increased compared to the previous year.

What are the consequences of high debt for investors of Astec Lifesciences?

High liabilities can pose a risk for investors of Astec Lifesciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Astec Lifesciences?

Low liabilities mean that Astec Lifesciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Astec Lifesciences affect the company?

An increase in liabilities of Astec Lifesciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Astec Lifesciences affect the company?

A decrease in the liabilities of Astec Lifesciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Astec Lifesciences?

Some factors that can influence the liabilities of Astec Lifesciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Astec Lifesciences so important for investors?

The liabilities of Astec Lifesciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Astec Lifesciences take to modify the liabilities?

To change its liabilities, Astec Lifesciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Astec Lifesciences pay?

Over the past 12 months, Astec Lifesciences paid a dividend of 1.5 INR . This corresponds to a dividend yield of about 0.21 %. For the coming 12 months, Astec Lifesciences is expected to pay a dividend of 1.78 INR.

What is the dividend yield of Astec Lifesciences?

The current dividend yield of Astec Lifesciences is 0.21 %.

When does Astec Lifesciences pay dividends?

Astec Lifesciences pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Astec Lifesciences?

Astec Lifesciences paid dividends every year for the past 3 years.

What is the dividend of Astec Lifesciences?

For the upcoming 12 months, dividends amounting to 1.78 INR are expected. This corresponds to a dividend yield of 0.25 %.

In which sector is Astec Lifesciences located?

Astec Lifesciences is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Astec Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Astec Lifesciences from 8/1/2023 amounting to 1.5 INR, you needed to have the stock in your portfolio before the ex-date on 7/21/2023.

When did Astec Lifesciences pay the last dividend?

The last dividend was paid out on 8/1/2023.

What was the dividend of Astec Lifesciences in the year 2024?

In the year 2024, Astec Lifesciences distributed 1.5 INR as dividends.

In which currency does Astec Lifesciences pay out the dividend?

The dividends of Astec Lifesciences are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Astec Lifesciences

Our stock analysis for Astec Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Astec Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.